Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effects.
作者信息
Remington Gary, Hahn Margaret
机构信息
Department of Psychiatry, University of Toronto, Centre for Addiction and Mental Health, Toronto, Ont., Canada.
Department of Psychiatry University of Toronto Centre for Addiction and Mental Health Toronto, Ont., Canada.
出版信息
J Psychiatry Neurosci. 2014 Jan;39(1):E1-2. doi: 10.1503/jpn.130222.
Abstract
摘要
相似文献
1
Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effects.
J Psychiatry Neurosci. 2014 Jan;39(1):E1-2. doi: 10.1503/jpn.130222.
2
Tardive dyskinesia from atypical antipsychotic agents in patients with mood disorders in a clinical setting.
J Affect Disord. 2013 Sep 25;150(3):868-71. doi: 10.1016/j.jad.2013.04.053. Epub 2013 May 30.
3
Differential diagnosis of tardive dyskinesia in an older woman taking antipsychotic medication.
Ann Clin Psychiatry. 2011 Nov;23(4):308-9.
4
Rational antipsychotic choice: weighing the risk of tardive dyskinesia and metabolic syndrome.
Harv Rev Psychiatry. 2011 Sep-Oct;19(5):271-6. doi: 10.3109/10673229.2011.614100.
5
[Risk factors for tardive movement disorders in schizophrenia].
Tijdschr Psychiatr. 2015;57(2):120-4.
6
Is there a real difference in severity of tardive dyskinesia between risperidone and olanzapine?
J Clin Psychiatry. 2010 Nov;71(11):1553-4; author reply 1554. doi: 10.4088/JCP.10lr06261yel.
7
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
J Clin Psychiatry. 2000;61 Suppl 3:16-21.
8
Drug-induced movement disorders.
Neurol Clin. 2015 Feb;33(1):153-74. doi: 10.1016/j.ncl.2014.09.011.
9
Olanzapine induced tardive dyskinesia treated successfully with quetiapine: a case report.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):276-7. doi: 10.1016/j.pnpbp.2010.09.008. Epub 2010 Sep 22.
10
Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia.
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:178-83. doi: 10.1016/j.pnpbp.2013.02.011. Epub 2013 Feb 26.
引用本文的文献
1
Off-label prescription of psychiatric drugs by non-psychiatrist physicians in three general hospitals in Germany.
Ann Gen Psychiatry. 2018 Feb 8;17:7. doi: 10.1186/s12991-018-0176-4. eCollection 2018.
本文引用的文献
1
Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology.
Neurology. 2013 Jul 30;81(5):463-9. doi: 10.1212/WNL.0b013e31829d86b6.
2
National trends in the office-based treatment of children, adolescents, and adults with antipsychotics.
Arch Gen Psychiatry. 2012 Dec;69(12):1247-56. doi: 10.1001/archgenpsychiatry.2012.647.
3
Off-label use of atypical antipsychotics: cause for concern?
CNS Drugs. 2012 May 1;26(5):383-90. doi: 10.2165/11632030-000000000-00000.
4
Genetics of tardive dyskinesia.
Int Rev Neurobiol. 2011;98:231-64. doi: 10.1016/B978-0-12-381328-2.00010-9.
5
Tardive dyskinesia: clinical presentation and treatment.
Int Rev Neurobiol. 2011;98:187-210. doi: 10.1016/B978-0-12-381328-2.00008-0.
6
Tardive dyskinesia and deficit schizophrenia.
Acta Psychiatr Scand. 2011 Nov;124(5):357-62. doi: 10.1111/j.1600-0447.2011.01751.x. Epub 2011 Aug 13.
7
Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs.
Handb Clin Neurol. 2011;100:601-16. doi: 10.1016/B978-0-444-52014-2.00043-4.
8
Increasing off-label use of antipsychotic medications in the United States, 1995-2008.
Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):177-84. doi: 10.1002/pds.2082. Epub 2011 Jan 6.
9
Spectrum of tardive syndromes: clinical recognition and management.
Postgrad Med J. 2011 Feb;87(1024):132-41. doi: 10.1136/pgmj.2010.103234. Epub 2010 Dec 3.
10
Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
Am J Geriatr Pharmacother. 2010 Aug;8(4):331-73. doi: 10.1016/j.amjopharm.2010.08.006.
Zotero 插件